Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Inovio Pharmaceuticals Inc. (INO) shares rose 4.65% to $2.25, outperforming competitors like Johnson & Johnson and Pfizer on a strong trading day. This rise ended a four-day losing streak, although the stock remains 24.47% below its 52-week high. Trading volume was significantly below the 50-day average. The NASDAQ and Dow Jones also saw gains.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments